Knowledge is sparse about the consequences of variation in prostate‐specific antigen (PSA)
testing rates in general practice. This study investigated associations between PSA testing …

Objectives To investigate the association between factors influencing prostate-specific
antigen (PSA) testing prevalence including prostate cancer risk factors (age, ethnicity …

Importance The diagnostic activity for prostate cancer has increased during the past
decades. However, the benefit and harm of the increased diagnostic activity have not been …

PURPOSE: We assess the influence of prostate specific antigen screening on trends in
mortality rates in patients with prostate cancer. MATERIALS AND METHODS: The incidence …

Background. Social differences in prostate cancer (PC) incidence and mortality might be
related to testing for prostate-specific antigen (PSA). Although routine PSA screening is not …

Introduction: Different patterns in the use of prostate-specific antigen (PSA) testing might
explain socioeconomic differences in prostate cancer incidence and mortality. We examined …

OBJECTIVES: To compare the preoperative characteristics, postoperative prostate-specific
antigen (PSA) doubling time (DT), and prostate cancer-specific mortality (PCSM) estimates …

Abstract Background In May 2012, the US Preventive Services Task Force issued a grade D
recommendation against PSA-based prostate cancer screening. Epidemiologists have …

Background: The effectiveness of prostate-specific antigen (PSA) for population screening
has presented controversial results in large trials and prior reviews. We investigated the …

Objectives Cross-sectional studies suggest that around 6% of men undergo prostate-specific
antigen (PSA) testing each year in UK general practice (GP). This longitudinal study aims to …